{"entity":{"type":"insider","cik":"0001380187","url":"/insider/0001380187","json_url":"/insider/0001380187.json","name":"Abdun-Nabi Daniel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":34,"first":"2007-05-31","last":"2019-06-25","span_basis":"filed_date"},"name_variants":[{"name":"Abdun-Nabi Daniel","source":"filing","n_filings":34,"first_seen":"2007-05-31","last_seen":"2019-06-25"}],"transactions":[{"id":8679092,"accession":"0001593968-19-001480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001480","line_url":"/filing/0001593968-19-001480#line-1","is_derivative":false,"issuer_cik":"0001380187","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380187","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16667.0,"shares_display":"16,667","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":15000.3,"total_display":"15,000.30","total_whole":"15,000","shares_owned_after":109351.0,"shares_owned_after_display":"109,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-25","scope":"insider"},{"id":8308190,"accession":"0001567619-19-006066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-006066","line_url":"/filing/0001567619-19-006066#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14565.0,"shares_display":"14,565","price_per_share":58.107,"price_display":"58.11","price_state":"stated","total_value":846328.455,"total_display":"846,328.46","total_whole":"846,328","shares_owned_after":142617.0,"shares_owned_after_display":"142,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-04","scope":"insider"},{"id":6166964,"accession":"0001567619-18-002811","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-18-002811","line_url":"/filing/0001567619-18-002811#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1319.0,"shares_display":"1,319","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":85735.0,"total_display":"85,735.00","total_whole":"85,735","shares_owned_after":166567.0,"shares_owned_after_display":"166,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-18","scope":"insider"},{"id":6166959,"accession":"0001567619-18-002811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002811","line_url":"/filing/0001567619-18-002811#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28220.0,"shares_display":"28,220","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":1834300.0,"total_display":"1,834,300.00","total_whole":"1,834,300","shares_owned_after":166567.0,"shares_owned_after_display":"166,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-14","filed_date":"2018-09-18","scope":"insider"},{"id":6029767,"accession":"0001567619-18-002215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-002215","line_url":"/filing/0001567619-18-002215#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30776.0,"shares_display":"30,776","price_per_share":59.4926,"price_display":"59.49","price_state":"stated","total_value":1830944.2576,"total_display":"1,830,944.26","total_whole":"1,830,944","shares_owned_after":166567.0,"shares_owned_after_display":"166,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-06","scope":"insider"},{"id":6029765,"accession":"0001567619-18-002215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002215","line_url":"/filing/0001567619-18-002215#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":60.5381,"price_display":"60.54","price_state":"stated","total_value":3632286.0,"total_display":"3,632,286.00","total_whole":"3,632,286","shares_owned_after":197343.0,"shares_owned_after_display":"197,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6461927,"accession":"0001140361-18-027713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-027713","line_url":"/filing/0001140361-18-027713#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15785.0,"shares_display":"15,785","price_per_share":52.1137,"price_display":"52.11","price_state":"stated","total_value":822614.7545,"total_display":"822,614.75","total_whole":"822,615","shares_owned_after":197343.0,"shares_owned_after_display":"197,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider"},{"id":6528019,"accession":"0001140361-18-000849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-000849","line_url":"/filing/0001140361-18-000849#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21906.0,"shares_display":"21,906","price_per_share":47.91,"price_display":"47.91","price_state":"stated","total_value":1049516.46,"total_display":"1,049,516.46","total_whole":"1,049,516","shares_owned_after":204134.0,"shares_owned_after_display":"204,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5141993,"accession":"0001140361-17-046253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-046253","line_url":"/filing/0001140361-17-046253#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":45.99,"price_display":"45.99","price_state":"stated","total_value":919800.0,"total_display":"919,800.00","total_whole":"919,800","shares_owned_after":204134.0,"shares_owned_after_display":"204,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-14","scope":"insider"},{"id":4090278,"accession":"0001140361-17-041378","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-041378","line_url":"/filing/0001140361-17-041378","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31508.0,"shares_display":"31,508","price_per_share":42.76659895899454,"price_display":"42.77","price_state":"stated","total_value":1347490.0,"total_display":"1,347,490.00","total_whole":"1,347,490","shares_owned_after":204134.0,"shares_owned_after_display":"204,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-03","filed_date":"2017-11-07","scope":"insider","n_lines":2},{"id":4788553,"accession":"0001140361-17-036963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-036963","line_url":"/filing/0001140361-17-036963#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":39.918,"price_display":"39.92","price_state":"stated","total_value":598770.0,"total_display":"598,770.00","total_whole":"598,770","shares_owned_after":204134.0,"shares_owned_after_display":"204,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-27","filed_date":"2017-09-29","scope":"insider"},{"id":4189823,"accession":"0001140361-17-034333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-034333","line_url":"/filing/0001140361-17-034333#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":37.21,"price_display":"37.21","price_state":"stated","total_value":558150.0,"total_display":"558,150.00","total_whole":"558,150","shares_owned_after":204134.0,"shares_owned_after_display":"204,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-05","scope":"insider"},{"id":4188579,"accession":"0001140361-17-001760","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-001760","line_url":"/filing/0001140361-17-001760#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28240.0,"shares_display":"28,240","price_per_share":31.2782,"price_display":"31.28","price_state":"stated","total_value":883296.368,"total_display":"883,296.37","total_whole":"883,296","shares_owned_after":189162.0,"shares_owned_after_display":"189,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-12","scope":"insider"},{"id":3282860,"accession":"0001140361-16-068373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-068373","line_url":"/filing/0001140361-16-068373#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8699.0,"shares_display":"8,699","price_per_share":43.74,"price_display":"43.74","price_state":"stated","total_value":380494.26,"total_display":"380,494.26","total_whole":"380,494","shares_owned_after":170966.0,"shares_owned_after_display":"170,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"},{"id":2331601,"accession":"0001140361-16-066876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-066876","line_url":"/filing/0001140361-16-066876#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8701.0,"shares_display":"8,701","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":365442.0,"total_display":"365,442.00","total_whole":"365,442","shares_owned_after":179665.0,"shares_owned_after_display":"179,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-24","scope":"insider"},{"id":3224038,"accession":"0001140361-16-061621","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-061621","line_url":"/filing/0001140361-16-061621","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8702.0,"shares_display":"8,702","price_per_share":40.17,"price_display":"40.17","price_state":"stated","total_value":349559.34,"total_display":"349,559.34","total_whole":"349,559","shares_owned_after":190739.0,"shares_owned_after_display":"190,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider","n_lines":3},{"id":8791081,"accession":"0001140361-15-045654","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-045654","line_url":"/filing/0001140361-15-045654#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22855.0,"shares_display":"22,855","price_per_share":39.17,"price_display":"39.17","price_state":"stated","total_value":895230.35,"total_display":"895,230.35","total_whole":"895,230","shares_owned_after":185368.0,"shares_owned_after_display":"185,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-24","filed_date":"2015-12-28","scope":"insider"},{"id":8791079,"accession":"0001140361-15-045654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-045654","line_url":"/filing/0001140361-15-045654#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40354.0,"shares_display":"40,354","price_per_share":38.99,"price_display":"38.99","price_state":"stated","total_value":1573402.46,"total_display":"1,573,402.46","total_whole":"1,573,402","shares_owned_after":185368.0,"shares_owned_after_display":"185,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-23","filed_date":"2015-12-28","scope":"insider"},{"id":4371453,"accession":"0001140361-13-045208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-045208","line_url":"/filing/0001140361-13-045208#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":749.0,"shares_display":"749","price_per_share":19.08,"price_display":"19.08","price_state":"stated","total_value":14290.92,"total_display":"14,290.92","total_whole":"14,291","shares_owned_after":103373.0,"shares_owned_after_display":"103,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-30","filed_date":"2013-12-09","scope":"insider"},{"id":5441803,"accession":"0001140361-13-023930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-023930","line_url":"/filing/0001140361-13-023930#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":12.07,"price_display":"12.07","price_state":"stated","total_value":9656.0,"total_display":"9,656.00","total_whole":"9,656","shares_owned_after":96011.0,"shares_owned_after_display":"96,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-31","filed_date":"2013-06-04","scope":"insider"},{"id":8899710,"accession":"0001140361-11-030988","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001140361-11-030988","line_url":"/filing/0001140361-11-030988","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78515.0,"shares_display":"78,515","price_per_share":24.167738266573267,"price_display":"24.17","price_state":"stated","total_value":1897529.97,"total_display":"1,897,529.97","total_whole":"1,897,530","shares_owned_after":40830.0,"shares_owned_after_display":"40,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-02","scope":"insider","n_lines":4},{"id":8899697,"accession":"0001140361-11-030988","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-11-030988","line_url":"/filing/0001140361-11-030988","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":24.91,"price_display":"24.91","price_state":"stated","total_value":2491000.0,"total_display":"2,491,000.00","total_whole":"2,491,000","shares_owned_after":40830.0,"shares_owned_after_display":"40,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-02","scope":"insider","n_lines":2},{"id":7178501,"accession":"0001140361-10-030843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-030843","line_url":"/filing/0001140361-10-030843#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10200.0,"shares_display":"10,200","price_per_share":18.65,"price_display":"18.65","price_state":"stated","total_value":190230.0,"total_display":"190,230.00","total_whole":"190,230","shares_owned_after":24145.0,"shares_owned_after_display":"24,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-29","filed_date":"2010-07-30","scope":"insider"},{"id":7178499,"accession":"0001140361-10-030843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-030843","line_url":"/filing/0001140361-10-030843#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7950.0,"shares_display":"7,950","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":150414.0,"total_display":"150,414.00","total_whole":"150,414","shares_owned_after":34345.0,"shares_owned_after_display":"34,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-28","filed_date":"2010-07-30","scope":"insider"},{"id":5996200,"accession":"0001367644-09-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001367644-09-000064","line_url":"/filing/0001367644-09-000064","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.2715,"price_display":"16.27","price_state":"stated","total_value":32543.0,"total_display":"32,543.00","total_whole":"32,543","shares_owned_after":20150.0,"shares_owned_after_display":"20,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-18","filed_date":"2009-08-20","scope":"insider","n_lines":3},{"id":5849241,"accession":"0001367644-09-000062","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-17","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":17.09,"price_display":"17.09","price_state":"stated","total_value":82032.0,"total_display":"82,032.00","total_whole":"82,032","shares_owned_after":28300.0,"shares_owned_after_display":"28,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849240,"accession":"0001367644-09-000062","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-16","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":17.4,"price_display":"17.40","price_state":"stated","total_value":19140.0,"total_display":"19,140.00","total_whole":"19,140","shares_owned_after":23850.0,"shares_owned_after_display":"23,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849239,"accession":"0001367644-09-000062","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-15","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":12215.0,"total_display":"12,215.00","total_whole":"12,215","shares_owned_after":22950.0,"shares_owned_after_display":"22,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849238,"accession":"0001367644-09-000062","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-14","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":17.38,"price_display":"17.38","price_state":"stated","total_value":10428.0,"total_display":"10,428.00","total_whole":"10,428","shares_owned_after":24950.0,"shares_owned_after_display":"24,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849236,"accession":"0001367644-09-000062","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-13","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.21,"price_display":"17.21","price_state":"stated","total_value":8605.0,"total_display":"8,605.00","total_whole":"8,605","shares_owned_after":26050.0,"shares_owned_after_display":"26,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849234,"accession":"0001367644-09-000062","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-12","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.18,"price_display":"17.18","price_state":"stated","total_value":8590.0,"total_display":"8,590.00","total_whole":"8,590","shares_owned_after":26650.0,"shares_owned_after_display":"26,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849232,"accession":"0001367644-09-000062","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-11","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.13,"price_display":"17.13","price_state":"stated","total_value":8565.0,"total_display":"8,565.00","total_whole":"8,565","shares_owned_after":27350.0,"shares_owned_after_display":"27,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849228,"accession":"0001367644-09-000062","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-10","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.11,"price_display":"17.11","price_state":"stated","total_value":8555.0,"total_display":"8,555.00","total_whole":"8,555","shares_owned_after":27850.0,"shares_owned_after_display":"27,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849227,"accession":"0001367644-09-000062","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-9","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":17.61,"price_display":"17.61","price_state":"stated","total_value":5283.0,"total_display":"5,283.00","total_whole":"5,283","shares_owned_after":22150.0,"shares_owned_after_display":"22,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849225,"accession":"0001367644-09-000062","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-8","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":17.57,"price_display":"17.57","price_state":"stated","total_value":5271.0,"total_display":"5,271.00","total_whole":"5,271","shares_owned_after":22450.0,"shares_owned_after_display":"22,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849224,"accession":"0001367644-09-000062","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-7","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":17.31,"price_display":"17.31","price_state":"stated","total_value":5193.0,"total_display":"5,193.00","total_whole":"5,193","shares_owned_after":25650.0,"shares_owned_after_display":"25,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849223,"accession":"0001367644-09-000062","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":3506.0,"total_display":"3,506.00","total_whole":"3,506","shares_owned_after":22750.0,"shares_owned_after_display":"22,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849221,"accession":"0001367644-09-000062","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.43,"price_display":"17.43","price_state":"stated","total_value":3486.0,"total_display":"3,486.00","total_whole":"3,486","shares_owned_after":23650.0,"shares_owned_after_display":"23,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849220,"accession":"0001367644-09-000062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.15,"price_display":"17.15","price_state":"stated","total_value":3430.0,"total_display":"3,430.00","total_whole":"3,430","shares_owned_after":27150.0,"shares_owned_after_display":"27,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849218,"accession":"0001367644-09-000062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.34,"price_display":"17.34","price_state":"stated","total_value":1734.0,"total_display":"1,734.00","total_whole":"1,734","shares_owned_after":25550.0,"shares_owned_after_display":"25,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"},{"id":5849216,"accession":"0001367644-09-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-09-000062","line_url":"/filing/0001367644-09-000062#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380187","owner_name":"Abdun-Nabi Daniel","owner_display_name":"Abdun-Nabi Daniel","owner_url":"/insider/0001380187","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.22,"price_display":"17.22","price_state":"stated","total_value":1722.0,"total_display":"1,722.00","total_whole":"1,722","shares_owned_after":25950.0,"shares_owned_after_display":"25,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-11","filed_date":"2009-08-13","scope":"insider"}],"collapsed":true,"next_cursor":"2009-08-11|5849216","ledger_fault":false,"count":{"value":84,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":81,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":84},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671584","name":"Aptevo Therapeutics Inc.","url":"/issuer/0001671584","role":"Director","n_filings":1,"first_seen":"2019-06-25","last_seen":"2019-06-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Director, Officer (CEO)","n_filings":33,"first_seen":"2007-05-31","last_seen":"2019-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380187","retrieved_at":"2026-08-24T15:42:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}